Suppr超能文献

朊病毒蛋白与 Aβ 寡聚物的结合有助于阿尔茨海默病的发病机制。

Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.

机构信息

School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan, 430070, China.

State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.

出版信息

Virol Sin. 2019 Oct;34(5):475-488. doi: 10.1007/s12250-019-00124-1. Epub 2019 May 15.

Abstract

A plethora of evidence suggests that protein misfolding and aggregation are underlying mechanisms of various neurodegenerative diseases, such as prion diseases and Alzheimer's disease (AD). Like prion diseases, AD has been considered as an infectious disease in the past decades as it shows strain specificity and transmission potential. Although it remains elusive how protein aggregation leads to AD, it is becoming clear that cellular prion protein (PrP) plays an important role in AD pathogenesis. Here, we briefly reviewed AD pathogenesis and focused on recent progresses how PrP contributed to AD development. In addition, we proposed a potential mechanism to explain why infectious agents, such as viruses, conduce AD pathogenesis. Microbe infections cause Aβ deposition and upregulation of PrP, which lead to high affinity binding between Aβ oligomers and PrP. The interaction between PrP and Aβ oligomers in turn activates the Fyn signaling cascade, resulting in neuron death in the central nervous system (CNS). Thus, silencing PrP expression may turn out be an effective treatment for PrP dependent AD.

摘要

大量证据表明,蛋白质错误折叠和聚集是各种神经退行性疾病(如朊病毒病和阿尔茨海默病)的潜在机制。与朊病毒病一样,过去几十年来,阿尔茨海默病一直被认为是一种传染病,因为它具有株特异性和传播潜力。尽管蛋白质聚集如何导致阿尔茨海默病仍然难以捉摸,但越来越清楚的是,细胞朊蛋白(PrP)在阿尔茨海默病发病机制中发挥重要作用。在这里,我们简要回顾了阿尔茨海默病的发病机制,并重点介绍了 PrP 如何促进阿尔茨海默病发展的最新进展。此外,我们提出了一个潜在的机制来解释为什么感染性病原体,如病毒,会导致阿尔茨海默病的发病机制。微生物感染导致 Aβ沉积和 PrP 的上调,这导致 Aβ寡聚体和 PrP 之间的高亲和力结合。PrP 和 Aβ 寡聚体之间的相互作用反过来激活了 Fyn 信号级联反应,导致中枢神经系统(CNS)中的神经元死亡。因此,沉默 PrP 表达可能是治疗 PrP 依赖性阿尔茨海默病的有效方法。

相似文献

1
Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.
Virol Sin. 2019 Oct;34(5):475-488. doi: 10.1007/s12250-019-00124-1. Epub 2019 May 15.
2
Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
J Alzheimers Dis. 2022;85(2):503-518. doi: 10.3233/JAD-215171.
3
The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
FEBS J. 2019 Jun;286(12):2355-2365. doi: 10.1111/febs.14819. Epub 2019 Apr 8.
4
Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a model of Alzheimer's disease.
J Biol Chem. 2018 Aug 24;293(34):13090-13099. doi: 10.1074/jbc.RA118.003319. Epub 2018 Jun 10.
6
Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
Brain Pathol. 2021 Sep;31(5):e12941. doi: 10.1111/bpa.12941. Epub 2021 Feb 23.
7
Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway.
ACS Chem Neurosci. 2013 Sep 18;4(9):1287-96. doi: 10.1021/cn400085q. Epub 2013 Jul 18.
9
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
Nat Neurosci. 2012 Sep;15(9):1227-35. doi: 10.1038/nn.3178. Epub 2012 Jul 22.
10
Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease.
Prion. 2013 Jan-Feb;7(1):37-41. doi: 10.4161/pri.22212. Epub 2012 Sep 17.

引用本文的文献

2
Evidence Suggesting That Alzheimer's Disease May Be a Transmissible Disorder.
Int J Mol Sci. 2025 Jan 9;26(2):508. doi: 10.3390/ijms26020508.
5
Molecular Mechanisms Associated with Neurodegeneration of Neurotropic Viral Infection.
Mol Neurobiol. 2024 May;61(5):2881-2903. doi: 10.1007/s12035-023-03761-6. Epub 2023 Nov 9.
6
Alzheimer's Disease and Its Possible Evolutionary Origin: Hypothesis.
Cells. 2023 Jun 13;12(12):1618. doi: 10.3390/cells12121618.

本文引用的文献

1
in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors.
Sci Adv. 2019 Jan 23;5(1):eaau3333. doi: 10.1126/sciadv.aau3333. eCollection 2019 Jan.
2
Genetic Study of Alzheimer's Disease in Saudi Population.
J Alzheimers Dis. 2019;67(1):231-242. doi: 10.3233/JAD-180415.
3
Prion dimer is heterogenous and is modulated by multiple negative and positive motifs.
Biochem Biophys Res Commun. 2019 Feb 5;509(2):570-576. doi: 10.1016/j.bbrc.2018.12.113. Epub 2018 Dec 29.
4
Genetic data and cognitively defined late-onset Alzheimer's disease subgroups.
Mol Psychiatry. 2020 Nov;25(11):2942-2951. doi: 10.1038/s41380-018-0298-8. Epub 2018 Dec 4.
5
Oxidative stress in Alzheimer disease as a target for therapy.
Bratisl Lek Listy. 2018;119(9):535-543. doi: 10.4149/BLL_2018_097.
7
Genetic association of the cytochrome c oxidase-related genes with Alzheimer's disease in Han Chinese.
Neuropsychopharmacology. 2018 Oct;43(11):2264-2276. doi: 10.1038/s41386-018-0144-3. Epub 2018 Jul 6.
9
Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a model of Alzheimer's disease.
J Biol Chem. 2018 Aug 24;293(34):13090-13099. doi: 10.1074/jbc.RA118.003319. Epub 2018 Jun 10.
10
An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk.
Neurobiol Aging. 2018 Jun;66:178.e1-178.e8. doi: 10.1016/j.neurobiolaging.2017.12.027. Epub 2018 Jan 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验